Clear Street’s SAB Biotherapeutics Warrant SABSW Stock Holding History
Bought
Maintained
Sold
Other funds holding SABSW
LP
GS
WAM
Clear Street's SABSW Position: Q2 2026 in Review
Clear Street increased its SAB Biotherapeutics Warrant (SABSW) stake by 0.38% in Q2 2026, buying an estimated $6 and bringing the position to 79,033 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #1312.
Clear Street first reported a position in SABSW in Q2 2023 and has held it in 8 quarters since. The position peaked at $2.63K in Q2 2025. 8 funds tracked by Wall St. Rank hold SABSW as of Q2 2026.
- Clear Street held 79,033 shares of SAB Biotherapeutics Warrant worth $1.01K as of Q2 2026.
- Clear Street bought 300 SAB Biotherapeutics Warrant shares in Q2 2026, an estimated $6.
- SAB Biotherapeutics Warrant made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #1312 holding.
- Clear Street first reported a position in SAB Biotherapeutics Warrant in Q2 2023 and has held it in 8 quarters since.
- Clear Street's SAB Biotherapeutics Warrant position peaked at $2.63K in Q2 2025.
- 8 funds tracked by Wall St. Rank held SAB Biotherapeutics Warrant as of Q2 2026.
Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.